FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/074172 [Registered on: 23/09/2024] Trial Registered Prospectively
Last Modified On: 06/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of the efficacy of two modes of administration of dexamethasone which include twin mix LA and submucosal injection in the intraoperative and postoperative outcome during mandibular third molar surgery 
Scientific Title of Study   Evaluating the Efficacy of Twin Mixed Local Anaesthesia and Local Anaesthesia with Submucosal Dexamethasone Injection in Mandibular Third Molar Surgery – Prospective Comparative Clinical Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Karthiga M 
Designation  Postgraduate trainee 
Affiliation  Sri Balaji Vidyapeeth 
Address  Department of Oral and Maxillofacial Surgery, Indira Gandhi Institute of Dental Sciences, Sri Balaji Vidyapeeth, Pillaiyarkuppam, Pondicherry.

Pondicherry
PONDICHERRY
607403
India 
Phone  8903208812  
Fax    
Email  umkarthiga@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Raghu K 
Designation  Professor 
Affiliation  Sri Balaji Vidyapeeth 
Address  Department of Oral and Maxillofacial Surgery, Indira Gandhi Institute of Dental Sciences, Sri Balaji Vidyapeeth, Pillaiyarkuppam, Pondicherry.


PONDICHERRY
607403
India 
Phone    
Fax    
Email  dr.raghuk@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Karthiga M 
Designation  POSTGRADUATE TRAINEE 
Affiliation  Sri Balaji Vidyapeeth 
Address  Department of Oral and Maxillofacial Surgery, Indira Gandhi Institute of Dental Sciences, Sri Balaji Vidyapeeth, Pillaiyarkuppam, Pondicherry.

Pondicherry
PONDICHERRY
607403
India 
Phone  8903208812  
Fax    
Email  umkarthiga@gmail.com  
 
Source of Monetary or Material Support  
Department of Oral and Maxillofacial Surgery, Indira Gandhi Institute of Dental Sciences, Sri Balaji Vidyapeeth, Pillaiyarkuppam, Pondicherry. 
 
Primary Sponsor  
Name  Karthiga M 
Address  Department of Oral and Maxillofacial Surgery, Indira Gandhi Institute of Dental Sciences, Sri Balaji Vidyapeeth, Pillaiyarkuppam, Pondicherry. 
Type of Sponsor  Other [PI] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Karthiga M  Indira Gandhi Institute of Dental Sciences  Department of Oral and Maxillofacial Surgery, Indira Gandhi Institute of Dental Sciences, Sri Balaji Vidyapeeth, Pillaiyarkuppam, Pondicherry.
Pondicherry
PONDICHERRY 
8903208812

umkarthiga@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE, INDIRA GANDHI INSTITUTE OF DENTAL SCIENCES  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Impacted mandibular third molar 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  LOCAL ANESTHESIA WITH SUBMUCOSAL DEXAMETHASONE  1.8ml of 2% lignocaine containing 1:200000 adrenaline as inferior alveolar nerve block and 1ml of 4mg dexamethasone as submucosal injection given proximal to surgical site (surrounding tissue) given once 
Intervention  TWIN MIX LOCAL ANESTHESIA  (1.8ml of 2% lignocaine containing 1:200000 adrenaline + 1 ml of 4mg dexamethasone as a single injection for inferior alveolar nerve block given once 
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Subjects above the age of 21 with mesioangular impacted mandibular third molar of Pell & Gregory Class-I, Level A.
Subjects who are in good physical status.
Subjects who could understand and are willing to take part in the study and likely to comply with all study procedures
 
 
ExclusionCriteria 
Details  Refusal to participate in the study.
Pregnancy and lactation.
Patient having systemic disorder like diabetes, hypertension, cardiac or neurological disorder.
Patients with reduced mouth opening (mouth opening above 30mm was considered normal)
Patient with history of drug allergy to lignocaine, dexamethasone, amoxicillin, metronidazole, diclofenac.
Patients with active infection.
Patient under any antibiotics or analgesics coverage.
Patient other than Pell & Gregory Class-I Level A.
Patients with severe oral manifestations of systemic disease.
Psychologic or psychiatric conditions that could influence response to treatment.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
POST OPERATIVE PAIN, FACIAL SWELLING AND MOUTH OPENING  7 days 
 
Secondary Outcome  
Outcome  TimePoints 
INTRAOPERATIVE PAIN  3 HOURS 
POST OPERATIVE PAIN, FACIAL SWELLING AND MOUTH OPENING  3rd day, 7th day 
 
Target Sample Size   Total Sample Size="39"
Sample Size from India="39" 
Final Enrollment numbers achieved (Total)= "39"
Final Enrollment numbers achieved (India)="39" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   04/10/2024 
Date of Study Completion (India) 15/04/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This is a prospective clinical trial with computer based randomisation to access pain during injection, onset and duration of analgesia, post operative pain, mouth opening and facial swelling. There is difference in pain during injection, onset of anaesthesia, duration of analgesia, reduction of postoperative pain, facial swelling followed by improvement in mouth opening.

 
Close